Y
Yulia Katsman
Researcher at University of Toronto
Publications - 7
Citations - 655
Yulia Katsman is an academic researcher from University of Toronto. The author has contributed to research in topics: Jurkat cells & Cell growth. The author has an hindex of 4, co-authored 6 publications receiving 536 citations.
Papers
More filters
Journal ArticleDOI
The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements
Stefan Schoenfelder,Mayra Furlan-Magaril,Borbala Mifsud,Filipe Tavares-Cadete,Filipe Tavares-Cadete,Robert Sugar,Biola M. Javierre,Takashi Nagano,Yulia Katsman,Moorthy Sakthidevi,Steven W. Wingett,Emilia Dimitrova,Andrew Dimond,Lucas Brandon Edelman,Sarah Elderkin,Kristina Tabbada,Elodie Darbo,Elodie Darbo,Simon Andrews,Bram Herman,Andy Higgs,Emily M LeProust,Cameron S. Osborne,Jennifer A. Mitchell,Nicholas M. Luscombe,Nicholas M. Luscombe,Peter Fraser +26 more
TL;DR: The results provide the first genome-wide catalog linking gene promoters to their long-range interacting elements and highlight the complex spatial regulatory circuitry controlling mammalian gene expression.
Journal ArticleDOI
A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential
Harry Y. Zhou,Yulia Katsman,Navroop K. Dhaliwal,Scott Davidson,Neil Macpherson,Moorthy Sakthidevi,Felicia Collura,Jennifer A. Mitchell +7 more
TL;DR: It is revealed that only the distal cluster containing SRR107 and SRR111, located >100 kb downstream from Sox2, is required for cis-regulation of Sox2 in ES cells, and homozygous deletion of this distal Sox2 control region (SCR) caused significant reduction in Sox2 mRNA and protein levels, loss of ES cell colony morphology, genome-wide changes in gene expression, and impaired neuroectodermal formation upon spontaneous differentiation to embryoid bodies.
Journal ArticleDOI
Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction.
TL;DR: It is found when using a mouse model of immune thrombocytopenia (ITP) that platelet nadir could not be maintained in the face of daily PLT antibody, making interpretation of treatment modalities difficult.
Journal ArticleDOI
Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis.
Xue-Zhong Ma,Tianru Jin,Darinka Sakac,Soad Fahim,Xin Zhang,Yulia Katsman,Meenakshi Bali,Donald R. Branch,Donald R. Branch +8 more
TL;DR: Evidence is provided that SHP-1 can negatively regulate growth of malignant human T cells and that lack of SHp-1 protein or function may be associated with lymphomagenesis, and the first evidence showing a protein product detectable in cells that is translated from an alternatively spliced form of SHP -1 mRNA is provided.
Journal ArticleDOI
Verotoxin A Subunit Protects Lymphocytes and T Cell Lines against X4 HIV Infection in Vitro
Pei Lin Shi,Beth Binnington,Darinka Sakac,Yulia Katsman,Stephanie Ramkumar,Jean Gariépy,Minji Kim,Donald R. Branch,Clifford A. Lingwood +8 more
TL;DR: It is speculated that VT1A may provide a benign approach to reduction of (X4 or R5) HIV cell susceptibility as well as up regulation of 30 genes, suggesting HIV protection via reduced gene activation.